The companies said the milestone represents a significant proof of concept for Open RAN’s interoperability and network ...

This was the first Proof-of-Concept call focused specifically on materials science and sustainability. A second call will open on September 1st, with an application deadline of October 15th, 2025.

News Business Wire AN2 Therapeutics Reports Key Insights from 200-Patient Observational Study in Acute Melioidosis, Laying Groundwork for Phase 2 Proof-of-Concept Trial of Epetraborole ...

Organon Provides Update on Phase 2 ELENA Proof-of-Concept Study Evaluating OG-6219 in Patients with Endometriosis-Related Pain Provided by Business Wire Jul 2, 2025, 4:30:00 AM ...

Dr Helen Bright, CSO, Centauri Therapeutics, said: "This latest publication from our talented team of scientists at Centauri provides clear, foundational proof-of-concept data demonstrating the ...

Autonomix Medical, Inc. Granted Approval to Expand Proof-of-Concept Human Clinical Study, Doubling Potential Addressable Market Beyond Pancreatic Cancer Pain Published Jun 5, 2025 8:45am EDT ...

AN2 Therapeutics Reports Key Insights from 200-Patient Observational Study in Acute Melioidosis, Laying Groundwork for Phase 2 Proof-of-Concept Trial of Epetraborole Published Jun 30, 2025 7:00am EDT ...